| Dr Adam Charles Sischy, MD | |
|
620 John Paul Jones Cir, Ob/gyn, Bldg 2 4th Floor, Portsmouth, VA 23708-2111 | |
| (757) 953-4300 | |
| Not Available |
| Full Name | Dr Adam Charles Sischy |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology |
| Location | 620 John Paul Jones Cir, Portsmouth, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588868129 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 24737 (Nebraska) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | 24737 (Nebraska) | Secondary |
| Entity Name | Bayview Physician Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508813387 PECOS PAC ID: 5597664201 Enrollment ID: O20031231000719 |
News Archive
The governing Board of the California Institute for Regenerative Medicine has approved a trio of awards, totaling approximately $4 million, to University of California San Diego School of Medicine researchers to advance studies of new stem cell-based treatments for multiple types of cancer and amyotrophic lateral sclerosis (ALS).
An antibody test for the virus that causes COVID-19, developed by researchers at The University of Texas at Austin in collaboration with Houston Methodist and other institutions, is more accurate and can handle a much larger number of donor samples at lower overall cost than standard antibody tests currently in use.
Latest results from a trial of a combination of two targeted therapies (dabrafenib and trametinib) to treat advanced melanoma have shown that patients are living significantly longer on the combined therapy than patients treated with another drug, vemurafenib, when used alone.
avVaa World Health Care Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announced the results of its first DRTV test week.
› Verified 3 days ago
| Entity Name | Piedmont Access To Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649240698 PECOS PAC ID: 3476512427 Enrollment ID: O20050304000592 |
News Archive
The governing Board of the California Institute for Regenerative Medicine has approved a trio of awards, totaling approximately $4 million, to University of California San Diego School of Medicine researchers to advance studies of new stem cell-based treatments for multiple types of cancer and amyotrophic lateral sclerosis (ALS).
An antibody test for the virus that causes COVID-19, developed by researchers at The University of Texas at Austin in collaboration with Houston Methodist and other institutions, is more accurate and can handle a much larger number of donor samples at lower overall cost than standard antibody tests currently in use.
Latest results from a trial of a combination of two targeted therapies (dabrafenib and trametinib) to treat advanced melanoma have shown that patients are living significantly longer on the combined therapy than patients treated with another drug, vemurafenib, when used alone.
avVaa World Health Care Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announced the results of its first DRTV test week.
› Verified 3 days ago
| Entity Name | Rappahannock Women's Health Center Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558303123 PECOS PAC ID: 9133166911 Enrollment ID: O20050413000517 |
News Archive
The governing Board of the California Institute for Regenerative Medicine has approved a trio of awards, totaling approximately $4 million, to University of California San Diego School of Medicine researchers to advance studies of new stem cell-based treatments for multiple types of cancer and amyotrophic lateral sclerosis (ALS).
An antibody test for the virus that causes COVID-19, developed by researchers at The University of Texas at Austin in collaboration with Houston Methodist and other institutions, is more accurate and can handle a much larger number of donor samples at lower overall cost than standard antibody tests currently in use.
Latest results from a trial of a combination of two targeted therapies (dabrafenib and trametinib) to treat advanced melanoma have shown that patients are living significantly longer on the combined therapy than patients treated with another drug, vemurafenib, when used alone.
avVaa World Health Care Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announced the results of its first DRTV test week.
› Verified 3 days ago
| Entity Name | Obhg Virginia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972807394 PECOS PAC ID: 9436323342 Enrollment ID: O20111110000430 |
News Archive
The governing Board of the California Institute for Regenerative Medicine has approved a trio of awards, totaling approximately $4 million, to University of California San Diego School of Medicine researchers to advance studies of new stem cell-based treatments for multiple types of cancer and amyotrophic lateral sclerosis (ALS).
An antibody test for the virus that causes COVID-19, developed by researchers at The University of Texas at Austin in collaboration with Houston Methodist and other institutions, is more accurate and can handle a much larger number of donor samples at lower overall cost than standard antibody tests currently in use.
Latest results from a trial of a combination of two targeted therapies (dabrafenib and trametinib) to treat advanced melanoma have shown that patients are living significantly longer on the combined therapy than patients treated with another drug, vemurafenib, when used alone.
avVaa World Health Care Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announced the results of its first DRTV test week.
› Verified 3 days ago
| Entity Name | Privia Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013042480 PECOS PAC ID: 4385682061 Enrollment ID: O20140603000011 |
News Archive
The governing Board of the California Institute for Regenerative Medicine has approved a trio of awards, totaling approximately $4 million, to University of California San Diego School of Medicine researchers to advance studies of new stem cell-based treatments for multiple types of cancer and amyotrophic lateral sclerosis (ALS).
An antibody test for the virus that causes COVID-19, developed by researchers at The University of Texas at Austin in collaboration with Houston Methodist and other institutions, is more accurate and can handle a much larger number of donor samples at lower overall cost than standard antibody tests currently in use.
Latest results from a trial of a combination of two targeted therapies (dabrafenib and trametinib) to treat advanced melanoma have shown that patients are living significantly longer on the combined therapy than patients treated with another drug, vemurafenib, when used alone.
avVaa World Health Care Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announced the results of its first DRTV test week.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Adam Charles Sischy, MD 620 John Paul Jones Cir, Ob/gyn, Bldg 2 4th Floor, Portsmouth, VA 23708-2111 Ph: (757) 953-4300 | Dr Adam Charles Sischy, MD 620 John Paul Jones Cir, Ob/gyn, Bldg 2 4th Floor, Portsmouth, VA 23708-2111 Ph: (757) 953-4300 |
News Archive
The governing Board of the California Institute for Regenerative Medicine has approved a trio of awards, totaling approximately $4 million, to University of California San Diego School of Medicine researchers to advance studies of new stem cell-based treatments for multiple types of cancer and amyotrophic lateral sclerosis (ALS).
An antibody test for the virus that causes COVID-19, developed by researchers at The University of Texas at Austin in collaboration with Houston Methodist and other institutions, is more accurate and can handle a much larger number of donor samples at lower overall cost than standard antibody tests currently in use.
Latest results from a trial of a combination of two targeted therapies (dabrafenib and trametinib) to treat advanced melanoma have shown that patients are living significantly longer on the combined therapy than patients treated with another drug, vemurafenib, when used alone.
avVaa World Health Care Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announced the results of its first DRTV test week.
› Verified 3 days ago
Dr. Allen Williams Ayres, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-4298 Fax: 757-953-7350 | |
Dr. Shawn Dean Redding, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-4335 | |
Emily Connell Kemner, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: Naval Medical Center Portsmouth, 620 John Paul Jones Circle, Portsmouth, VA 23708 Phone: 518-522-0676 | |
Dr. Deborah Jane Wiese, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-0399 Fax: 757-953-1007 | |
Dr. Kelly Ann Palumbo, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-4601 | |
Syed Ahmed Hussain, Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-5000 | |
Shorty Johansson, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-0669 |